| [1] |
Hezel AF,Zhu AX. Systemic therapy for biliary tract cancers[J]. Oncologist,2008,13(4):415-23.
|
| [2] |
Wu MC.Huang Jiasi Surgery[M].7th Edition.Beijing:People’s Medical Publishing House,2008:1822-5.[吴孟超.黄家驷外科学 [M] 7版.北京:人民卫生出版社,2008:1822-5.]
|
| [3] |
Eckel F, Schmid RM. Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials [J]. Br J Cancer,2007, 96 (6):896-902.
|
| [4] |
Kornek GV, Schuell B, Laengle F, et al. Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer:A randomised phase II trial[J]. Ann Oncol,2004,15(3):478-83.
|
| [5] |
Ducreux M, Van Cutsem E, Van Laethem JL, et al. A randomised phase Ⅱtrial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial[J]. Eur J Cancer,2005, 41 (3):398-403.
|
| [6] |
Rao S, Cunningham D, Hawkins RE, et al. Phase Ⅲstudy of 5F U, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer[J]. Br J Cancer,2005,92(9):1650-4.
|
| [7] |
Gebbia V, Giuliani F, Maiello E, et al. Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase Ⅱstudy[J].J Clin Oncol, 2001, 19(20): 4089-91.
|
| [8] |
Hong SM, Cho H, Moskaluk CA, et al. Measurement of the invasion depth of extrahepatie bile duct carcinoma: an alternative method overcoming the current T classification problems of the AJCC staging system[J]. Am J Surg Patho1,2007,31(2):199-206.
|
| [9] |
Nelson JW, Ghafoori AP, Willett CG, et al.Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma[J]. Int J Radiat Oncol Biol Phys,2009,73(1):148-53.
|
| [10] |
Woo SM,Ryu JK,Lee SH,et al. Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma [J]. Ann Surg Oncol, 20 07,14(11):3195-201.
|
| [11] |
Ramacciato G, Di Benedetto F, Cautero N, et al. Prognostic factors and long term outcome after surgery for hilar cholangiocarcinoma. Univariate and multivariate analysis[J]. Chir Ital,2004,56(6):749-59.
|
| [12] |
Ebata T, Nagino M, Kamiya J, et al. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases[J]. Ann Surg,2003,238(5):720-7.
|
| [13] |
Rea DJ, Munoz-Juarez M, rnell MB, et al. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients[J]. Arch Surg,2004,139(5):514-23.
|
| [14] |
Khan SA, Davidson BR, Goldin R, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document [J]. Gut,2002,51 Suppl 6:VI1-9.
|
| [15] |
Guglielmi A, Ruzzenente A, Campagnaro T, et al. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection[J]. World J Surg,2009,33(6):1247-54.
|
| [16] |
Nakagawa T, Kamiyama T, Kurauchi N, et al. Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma[J]. World J Surg,2005,29(6):728-33.
|
| [17] |
d e J o n g M C , H o n g S M , A u g u s t i n e M M , e t a l .Hi l a r cholangiocarcinoma: tumor depth as a predictor of outcome[J]. Arch Surg,2011,146(6):697-703.
|
| [18] |
Vern-Gross TZ, Shivnani AT, Chen K, et al. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis[J]. Int J Radiat Oncol Biol Phys,2011,81(1): 189-98.
|
| [19] |
Nagahashi m, Shirai Y, Wakai T, et al. Depth of invasion determines the postresectional prognosis for patients with T1 extrahepatic cholangiocarcinoma[J]. Cancer,2010,116(2):400-5.
|
| [20] |
Hong SM, Cho H, Moskaluk CA, et al. Measurement of the invasion depth of extrahepatic bile duct carcinoma: An alternative method overcoming the current T classification problems of the AJCC staging system[J].Am J Surg Patho1,2007,31(2):199-206.
|
| [21] |
Kloek JJ, Ten Kate FJ, Busch OR, et al. Surgery for extrahepatic cholangiocarcinoma: predictors of survival[J]. HPB(Oxford), 20 08,10(3):190-5.
|
| [22] |
Ribero D, Amisano M, Lo Tesoriere R, et al. Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma[J]. Ann Surg,2011,254(5):776-81;discussion 781-3.
|
| [23] |
Tamandl D, Herberger B, Gruenberger B, et al. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma[J]. Ann Surg Oncol,2008,15(10):2787-94.
|
| [24] |
Sakamoto E,Nimura Y,Hayakawa N,et al.The pattern of infiltration at the proximal border of hilar bile duct carcinoma:a histologic analysis of 62 resected cases[J].Ann Surg,1998,227(3):405-11.
|
下载:
